GO TO CORPORATE ABOUT US WHAT WE DO INVESTOR & MEDIA CAREERS DIVERSITY IN THE BOARD Target figure for the underrepresented gender in the Board In 2013, the Board of Directors set a target figure for female board members elected by the general meeting to 15% (corresponding to one member). Considering the Board's current composition as well as the composition of the boards of comparable companies, the target figure is regarded as realistic and ambitious. The time horizon, within which the set target figure is sought to be achieved, is determined at four years having regard to the continuity of the Board. In other management levels, the company currently has more than 40% of each gender and as such the share of gender is regarded equal. Over time, should the share for either gender drop below 40%, the company will prepare a policy to increase the share of the underrepresented gender. Corporate Governance Corporate Governance Reports Articles of Association Remuneration Policy Diversity in the Board CONTACT US +45 33 26 83 83 info@bavarian-nordic.com FOLLOW US ABOUT US Bavarian Nordic is a biopharmaceutical company focused on the development and manufacturing of cancer immunotherapies and vaccines for infectious diseases. OUR LOCATIONS © 2015 Bavarian Nordic | Disclaimer/Privacy | Cookies | Sitemap This website uses cookies to collect statistical information on the use of our website with the goal of improving user experience. To find out more about cookies on this website, see our cookie policy.

GO TO CORPORATE ABOUT US WHAT WE DO INVESTOR & MEDIA CAREERS MARTINSRIED, GERMANY The Martinsried facility is located within one of the leading European biotechnology regions - the Biotech Region of Munich, Germany. The new facility consists of approximately 3,300 square meters of office and research & development facilities. The state-of-the-art laboratories are classified and approved according to European regulations. Approximately 100 employees work at the Martinsried facility in the following functions: Research & Development (including Research, Preclinical, Vaccine Development, Clinical Development, Process Development, Analytical Development, Bioinformatics), Regulatory Affairs, Patents and IT. OUR LOCATIONS OUR LOCATIONS ADDRESS Bavarian Nordic GmbH Fraunhoferstrasse 13 D-82152 Martinsried Germany Tel: +49 89 255 446 300 Fax: +49 89 255 446 333 E-mail: info@bavarian-nordic.com General Manager: Paul Chaplin, PhD VAT No: DE 813 250 971 Reg: Amtsgericht München HRB 155 872 MAP CONTACT US +45 33 26 83 83 info@bavarian-nordic.com FOLLOW US ABOUT US Bavarian Nordic is a biopharmaceutical company focused on the development and manufacturing of cancer immunotherapies and vaccines for infectious diseases. OUR LOCATIONS © 2015 Bavarian Nordic | Disclaimer/Privacy | Cookies | Sitemap This website uses cookies to collect statistical information on the use of our website with the goal of improving user experience. To find out more about cookies on this website, see our cookie policy.